Related Experiment Video
Updated: Jul 28, 2025
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
[A case of malignant peritoneal mesothelioma]
1General Surgery of Ziyang First People's Hospital, Ziyang 641300, China.
Abstract:
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleural cavity, followed by the peritoneum and pericardium. Malignant peritoneal mesothelioma (MPM) accounts for 10%-15% of all mesothelioma. The most important risk factor for MPM is exposure to asbestos. MPM has no specific clinical symptoms, imaging and histopathology are critical for the diagnosis. There are currently no generally accepted guidelines for curative treatment of MPM. The patient mainly presented with abdominal pain, abdominal distension and discomfort. Due to extensive omentum metastasis, no further surgical treatment was performed. Pemetrexed combined with cisplatin chemotherapy was given for 2 cycles, and the patient is still alive.
Insights
Malignant peritoneal mesothelioma (MPM) is a rare cancer linked to asbestos exposure. This case highlights diagnostic challenges and the use of chemotherapy when surgery isn't possible.
Area of Science:
- Oncology
- Pathology
Background:
- Malignant mesothelioma is a rare, aggressive cancer originating in the mesothelium.
- Malignant peritoneal mesothelioma (MPM) constitutes 10-15% of all mesothelioma cases.
- Asbestos exposure is the primary risk factor for MPM development.
Observation:
- MPM often lacks specific clinical symptoms, necessitating imaging and histopathology for diagnosis.
- A patient presented with abdominal pain, distension, and discomfort.
- Extensive omentum metastasis precluded surgical intervention.
Findings:
- The patient received two cycles of pemetrexed and cisplatin chemotherapy.
- The patient remains alive following treatment.
Implications:
- This case underscores the diagnostic complexities of MPM.
- It demonstrates the potential role of chemotherapy in managing advanced MPM when curative surgery is not an option.
- Further research into standardized curative treatment guidelines for MPM is warranted.
